Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 233 of 5804
-
Can a vaccine boost TB treatment? new trial aims to find out
⭐️ VACCINE ⭐️ Not yet recruitingThis study is being done to test an experimental study vaccine compared to a placebo. The experimental study vaccine is called ID93 + GLA-SE. ID93 + GLA-SE has been used in humans in research but has not been approved for use in medical care. This study will be the first to test …
Phase: PHASE2 • Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:05 UTC
-
Stem cells may replace painful bone graft for kids with cleft lip
Disease control Not yet recruitingThe objective of this study is to compare the safety and efficacy of a bone tissue engineering kit - composed of 10⁶ autologous mesenchymal stem cells derived from deciduous dental pulp combined with Bio-Oss® Collagen - with secondary autogenous iliac crest bone grafting for alve…
Phase: PHASE3 • Sponsor: Instituto de Tecnologia do Paraná • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Misted chemotherapy shows promise for Hard-to-Treat abdominal cancers
Disease control Not yet recruitingThis phase III trial studies how well pressurized intraperitoneal aerosolized chemotherapy (PIPAC) with mitomycin works versus (vs) standard chemotherapy (leucovorin calcium, fluorouracil, and irinotecan hydrochloride \[FOLFIRI regimen\] plus bevacizumab) in treating patients wit…
Phase: PHASE3 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Cannabis extract shows promise for rare genetic disorder in new trial
Symptom relief Not yet recruitingThe FENRTT2 study will investigate the efficacy and safety of a medicinal cannabis plant extract with extremely low THC (delta-9-tetrahydrocannabinol), NTI164, on Rett syndrome (RTT) in a crossover design. RTT is a devastating rare genetic condition affecting females and involves…
Phase: PHASE2, PHASE3 • Sponsor: Fenix Innovation Group • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New hope for frail hodgkin patients: immunotherapy-chemo combo shows promise
Disease control Recruiting nowThis phase II trial tests how well pembrolizumab in addition to chemotherapy (gemcitabine, brentuximab vedotin, and dacarbazine) works in treating frail patients with newly diagnosed Hodgkin lymphoma who aren't candidates for standard anthracycline-based treatment. Immunotherapy …
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a gout drug and a blood thinner stop second strokes?
Disease control Not yet recruitingThe ARCHIMEDES study (Anti-inflammatory and anti-thRombotic therapy with colCHicine and low dose rIvaroxaban for Major adverse cardiovascular Events reDuction in ischEmic Stroke) will be a randomized, double-blind, 2x2 factorial clinical trial, which will include at least 3000 an…
Phase: PHASE4 • Sponsor: Brazilian Clinical Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for bile duct cancer: combo therapy aims to boost survival
Disease control Not yet recruitingThe goal of this clinical trial is to etablish whether adding Mitazalimab to standard chemotherapy is more effective than standard chemotherapy alone in people with advanced bile duct cancer. It will also learn about the safety of Mitazalimab. The main questions it aims to answe…
Phase: PHASE2, PHASE3 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Nasal spray could reverse sudden blindness in groundbreaking trial
Disease control Recruiting nowThis is a phase 3, randomized, multicenter, vehicle-controlled, double-masked study to evaluate the efficacy and safety of intranasal cenegermin compared with vehicle control in adult participants with NAION. Approximately 272 participants who meet all eligibility criteria will b…
Phase: PHASE3 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New radioactive therapy targets Hard-to-Treat prostate cancer
Disease control Not yet recruitingIn this study it is aimed to analyze the efficacy and safety of Tb-161 PSMA I\&T in the 7.4 GBq activity in a large patient group of Lu-177 PSMA naïve mCRPC patients. 3 cycles of Tb-161 PSMA will be administered with 6 weeks periods. After each cycle a triple bed quantitative sin…
Phase: PHASE2 • Sponsor: Ankara University • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New cocktail of drugs aims to tackle returning myeloma
Disease control Recruiting nowThe primary objective of this Phase Ib/II trial is to study the safety and tolerability of the combination of selinexor, carfilzomib, isatuximab-OBDS (on body delivery system) and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma, who have received a…
Phase: PHASE1, PHASE2 • Sponsor: Natalie Callander • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Could a diabetes pill save lives in septic shock?
Disease control Not yet recruitingMicrocirculatory dysfunction is a key driver of organ failure and mortality in septic shock, characterized by endothelial injury and impaired vasoregulation. Despite its strong prognostic value, it remains unaddressed by current therapies. SGLT-2 inhibitors (SGLT-2i) have shown p…
Phase: PHASE3 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo aims to shrink melanoma before surgery
Disease control Not yet recruitingThis is a phase II, open label clinical trial determining efficacy of Fianlimab in combination with Cemiplimab in subjects with Melanoma. These are subjects who will have surgery to remove their cancer.
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New hope for ovarian cancer: Rina-S faces off against chemo in major trial
Disease control Recruiting nowThis Phase 3 study will be conducted in different countries around the world with up to about 688 participants. The purpose of this study is to evaluate how well Rina-S works against ovarian cancer in combination with or without bevacizumab and how it compares to an investigator…
Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New drug cocktail aims to make ovarian tumors operable
Disease control Not yet recruitingThis is a single-center, single-arm clinical study to evaluate the efficacy and safety of iparomlimab and tovorilimab (QL1706) combined with paclitaxel, carboplatin, and bevacizumab as neoadjuvant therapy for advanced ovarian cancer.
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a neck surgery slow Alzheimer's? new trial aims to find out
Disease control Not yet recruitingThis is a multicenter, prospective, open-label, endpoint-blinded randomized controlled clinical study. We aim to evaluate the safety and efficacy of deep cervical lymphovenous anastomosis (LVA) combined with routine treatment for patients with moderate Alzheimer's disease, compar…
Phase: NA • Sponsor: Southwest Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Robot and 3D imaging join forces to spot lung cancer in HIV patients
Diagnosis Not yet recruitingThis multicenter study evaluates a full-situational awareness robotic bronchoscopy system combined with CBCT-based multimodal image fusion for diagnosing lung nodules in people living with HIV (PLWH). Lung nodules are small lesions that may be benign or cancerous. In PLWH, accur…
Phase: NA • Sponsor: wu qingguo • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Glow-in-the-Dark dye could speed up prostate cancer detection
Diagnosis Not yet recruitingThis study aims to validate the accuracy of the infrared fluorescence rapid detection technique for the diagnosis of prostate biopsy specimens, and to compare it with intraoperative frozen section and conventional paraffin section (the gold standard), so as to evaluate its feasib…
Sponsor: Xiangya Hospital of Central South University • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
Tailored HIIT may boost fitness in stubborn heart failure
Disease control Not yet recruitingCardiovascular-Kidney-Metabolic (CKM) Syndrome is a continuous clinical disease spectrum integrating cardiovascular, renal, and metabolic disorders. Heart failure with preserved ejection fraction (HFpEF) is considered Stage 4 of CKM syndrome, characterized primarily by impairment…
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New daily pill aims to tame psoriatic arthritis symptoms
Disease control Not yet recruitingRandomized trial aimed to assess in adults with PsA the effect of oral CBP-0276 administrated at a dose of 200mg QD, or 800mg QD vs. Placebo for CBP-0276 for 24 weeks. Primary outcome is the change at least 20% on severity of symptoms eat week 24, using the American College Rheum…
Phase: PHASE2 • Sponsor: Clarent Biopharma, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a nasal spray of insulin shield the aging brain from Post-Surgery confusion?
Prevention Not yet recruitingPostoperative delirium (POD) is highly prevalent in older patients with type 2 diabetes mellitus (T2DM). Cerebral insulin resistance is considered a key pathophysiological mechanism underlying this association. This study aims to investigate whether intranasal insulin (INI) can p…
Phase: NA • Sponsor: Weidong Mi • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC